Penson RT - Search Results

1

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.

Corcoran RB, Do KT, Kim JE, Cleary JM, Parikh AR, Yeku OO, Xiong N, Weekes CD, Veneris J, Ahronian LG, Mauri G, Tian J, Norden BL, Michel AG, Van Seventer EE, Siravegna G, Camphausen K, Chi G, Fetter IJ, Brugge JS, Chen H, Takebe N, Penson RT, Juric D, Flaherty KT, Sullivan RJ, Clark JW, Heist RS, Matulonis UA, Liu JF, Shapiro GI. Corcoran RB, et al. Among authors: penson rt. Clin Cancer Res. 2024 May 1;30(9):1739-1749. doi: 10.1158/1078-0432.CCR-23-3135. Clin Cancer Res. 2024. PMID: 38456660 Free PMC article. Clinical Trial.

2

A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.

Duska LR, Penson R, Supko JG, Finkelstein DM, Makastorsis T, Gallagher J, Borden K, Goodman A, Fuller AF, Nikrui N, Seiden MV. Duska LR, et al. Clin Cancer Res. 1999 Jun;5(6):1299-305. Clin Cancer Res. 1999. PMID: 10389912 Clinical Trial.

3

Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel.

Penson RT, Kronish K, Duan Z, Feller AJ, Stark P, Cook SE, Duska LR, Fuller AF, Goodman AK, Nikrui N, MacNeill KM, Matulonis UA, Preffer FI, Seiden MV. Penson RT, et al. Int J Gynecol Cancer. 2000 Jan;10(1):33-41. doi: 10.1046/j.1525-1438.2000.00003.x. Int J Gynecol Cancer. 2000. PMID: 11240649

4

The clinical utility of liposomal doxorubicin in recurrent ovarian cancer.

Campos SM, Penson RT, Mays AR, Berkowitz RS, Fuller AF, Goodman A, Matulonis UA, Muzikansky A, Seiden MV. Campos SM, et al. Among authors: penson rt. Gynecol Oncol. 2001 May;81(2):206-12. doi: 10.1006/gyno.2000.5980. Gynecol Oncol. 2001. PMID: 11330951

5

A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumors.

Penson RT, Supko JG, Seiden MV, Fuller AF, Berkowitz RS, Goodman A, Campos SM, MacNeill KM, Cook S, Matulonis UA. Penson RT, et al. Cancer. 2001 Sep 1;92(5):1156-67. doi: 10.1002/1097-0142(20010901)92:5<1156::aid-cncr1434>3.0.co;2-g. Cancer. 2001. PMID: 11571729 Clinical Trial.

6

Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors.

Campos SM, Matulonis UA, Penson RT, Lee H, Berkowitz RS, Duska LR, Fuller AF Jr, Wilson KS, Puchalski TA, Supko JG, Seiden MV. Campos SM, et al. Among authors: penson rt. Gynecol Oncol. 2003 Sep;90(3):610-8. doi: 10.1016/s0090-8258(03)00373-1. Gynecol Oncol. 2003. PMID: 13678734 Clinical Trial.

7

Phase II trial of anastrozole in women with asymptomatic müllerian cancer.

del Carmen MG, Fuller AF, Matulonis U, Horick NK, Goodman A, Duska LR, Penson R, Campos S, Roche M, Seiden MV. del Carmen MG, et al. Gynecol Oncol. 2003 Dec;91(3):596-602. doi: 10.1016/j.ygyno.2003.08.021. Gynecol Oncol. 2003. PMID: 14675683 Clinical Trial.

8

Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies.

Penson RT, Seiden MV, Goodman A, Fuller AF Jr, Berkowitz RS, Matulonis UA, Krasner C, Lee H, Atkinson T, Campos SM; Gynecologic Oncology Research Program at Dana Farber/Partners CancerCare. Penson RT, et al. Gynecol Oncol. 2004 Jun;93(3):702-7. doi: 10.1016/j.ygyno.2004.02.028. Gynecol Oncol. 2004. PMID: 15196868 Clinical Trial.

9

Attitudes to chemotherapy in patients with ovarian cancer.

Penson RT, Dignan F, Seiden MV, Lee H, Gallagher CJ, Matulonis UA, Olson K, Gibbens I, Gore ME. Penson RT, et al. Gynecol Oncol. 2004 Aug;94(2):427-35. doi: 10.1016/j.ygyno.2004.05.034. Gynecol Oncol. 2004. PMID: 15297184

10

A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.

Berkenblit A, Seiden MV, Matulonis UA, Penson RT, Krasner CN, Roche M, Mezzetti L, Atkinson T, Cannistra SA. Berkenblit A, et al. Among authors: penson rt. Gynecol Oncol. 2004 Dec;95(3):624-31. doi: 10.1016/j.ygyno.2004.08.028. Gynecol Oncol. 2004. PMID: 15581974 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page